Laura Plumlee v. Pfizer, Inc.
This text of 664 F. App'x 651 (Laura Plumlee v. Pfizer, Inc.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Ninth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
Opinion
MEMORANDUM **
Plaintiff Laura Plumlee appeals the dismissal with prejudice of her First Amended Complaint pursuant to Federal Rule of Civil Procedure 12(b)(6). We have jurisdiction pursuant to 28 U.S.C. § 1291, and we affirm.
The district court dismissed Plumlee’s First Amended Complaint with prejudice because her claims were time-barred under the three- and four-year statutes of limitations applicable to her claims. On appeal, Plumlee alleges that she did not learn of Pfizer’s alleged misrepresentations concerning Zoloft’s efficacy until May 2012, and that her delayed discovery of Pfizer’s alleged misrepresentations extends the statute of limitations applicable to her claims under the “discovery rule.” Under California law,'the discovery rule *653 delays accrual of claims only when a plaintiff has no reason to suspect wrongdoing and can not discover his or her claims with reasonable diligence. See, e.g., Norgart v. Upjohn Co., 21 Cal.4th 383, 87 Cal.Rptr.2d 453, 981 P.2d 79, 88-89 (1999).
The discovery rule does not extend the statutes of limitations applicable to Plum-lee’s otherwise time-barred claims. Plum-lee alleged that she stopped taking Zoloft’s generic equivalent in June 2008 because she believed it was ineffective for treating her depression, contrary to Pfizer’s representations. The district court did not err in determining that Plumlee therefore had “reason to' suspect an injury and some wrongful cause” such that she had inquiry notice by June 2008. See Fox v. Ethicon Endo-Surgery, Inc., 35 Cal.4th 797, 27 Cal.Rptr.3d 661, 110 P.3d 914, 917, 920 (Cal. 2005).
Plumlee did not sue Pfizer until January 2013, more than four years after she had reason to suspect wrongdoing on Pfizer’s part. Therefore, to delay accrual of her otherwise time-barred claims under the discovery rule, Plumlee needed to allege that she exercised reasonable diligence to discover the factual bases for her claims within the three- and four-year limitations periods beginning in June 2008 and that she was unable to discover the factual bases for her claims, despite her reasonable diligence. See Grisham v. Philip Morris U.S.A., Inc., 40 Cal.4th 623, 54 Cal.Rptr.3d 735, 151 P.3d 1151, 1159 (2007) (“[A] plaintiff whose complaint shows on its face that his claim would be barred without the benefit of the discovery rule must specifically plead facts to show (1) the time and manner of discovery and (2) the inability to have made earlier discovery despite reasonable diligence.” (internal quotations and citations omitted)). Although Plumlee alleged the “time and manner of discovery” of the factual bases of her claims—Plumlee alleged she first discovered the bases for her claims when she watched a 60 Minutes rerun discussing Zoloft’s alleged ineffectiveness in May 2012—Plumlee failed to allege any facts that she was unable to discover the factual bases of her claims earlier despite exercising reasonable diligence. Id. In fact, Plum-lee failed to allege any facts that she exercised any diligence at all to discover the factual bases of her claims between June 2008 and May 2012. 1 Under the discovery rule, Plumlee’s failure to allege any facts that she exercised reasonable diligence between June 2008 and May 2012, or that she was unable to discover the factual bases for her claims between June 2008 and May 2012 despite exercising reasonable diligence, constitutes a sufficient basis for affirming the district court’s dismissal with prejudice of her First Amended Complaint. Id.
On appeal, Plumlee argues that even had she exercised reasonable diligence to discover the factual bases of her claims during the applicable limitations periods, she would not have discovered any information concerning Zoloft’s alleged ineffectiveness because no information criticizing Zoloft’s efficacy existed to which a reasonably diligent consumer would have been exposed. However, the district court took judicial notice of an extensive record of documents—all publicly available during the relevant limitations periods—which discussed Pfizer’s unpublished clinical trials and the allegation that Zoloft was no more effective than a placebo. The district *654 court did not-err in taking judicial notice of these documents. See Von Saher v. Norton Simon Museum of Art at Pasadena, 592 F.3d 954, 960 (9th Cir. 2010) (holding that a court may take judicial notice of publications to establish what was in the public realm at the time); Seven Arts Filmed Entm’t Ltd. v. Content Media Corp. PLC, 733 F.3d 1251, 1254 (9th Cir. 2013) (stating that, although courts are required to accept as true well-pleaded allegations of material fact, courts are not “required to accept as true allegations that contradict ... matters properly subject to judicial notice ...” (quoting Daniels-Hall v. Nat'l Educ. Ass’n, 629 F.3d 992, 998 (9th Cir. 2010))). The judicially noticed documents either identified Zoloft specifically or referred to antidepressants generally, just as the 60 Minutes segment that Plumlee alleges to have imparted notice did. Therefore, the district court properly rejected Plumlee’s allegation that no information questioning Zoloft’s efficacy existed within the three- and four-year limitations periods beginning in June 2008 to which a reasonably diligent consumer would have been exposed. Seven Arts Filmed Entm’t Ltd., 733 F.3d at 1254.
Because Plumlee’s individual claims are time-barred, she cannot serve as a class representative. See Lierboe v. State Farm Mut. Auto. Ins. Co., 350 F.3d 1018, 1022 (9th Cir. 2003).
The district court also did not abuse its discretion in dismissing Plumlee’s claims with prejudice. A district court does not abuse its discretion when it denies leave to amend because the plaintiff “did not propose any new facts or legal theories for an amended complaint and therefore gave the [cjourt no basis to allow an amendment.” See Gardner v. Martino, 563 F.3d 981, 991 (9th Cir. 2009). The district court warned Plumlee that failure to cure the deficiencies in her original complaint would result in a dismissal with prejudice.
Free access — add to your briefcase to read the full text and ask questions with AI
Related
Cite This Page — Counsel Stack
664 F. App'x 651, Counsel Stack Legal Research, https://law.counselstack.com/opinion/laura-plumlee-v-pfizer-inc-ca9-2016.